BR9711879A - Derivados de 1h - pirido ¬3,4-b¾ indol -4- carboxamida sua prepara-Æo e sua aplica-Æo em terap-utica - Google Patents

Derivados de 1h - pirido ¬3,4-b¾ indol -4- carboxamida sua prepara-Æo e sua aplica-Æo em terap-utica

Info

Publication number
BR9711879A
BR9711879A BR9711879A BR9711879A BR9711879A BR 9711879 A BR9711879 A BR 9711879A BR 9711879 A BR9711879 A BR 9711879A BR 9711879 A BR9711879 A BR 9711879A BR 9711879 A BR9711879 A BR 9711879A
Authority
BR
Brazil
Prior art keywords
pyrido
carboxamide
therapeutics
indole
derivatives
Prior art date
Application number
BR9711879A
Other languages
English (en)
Inventor
Yannick Evanno
Mireille Sevrin
Christian Maloizel
Odette Legalloudec
Pascal George
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of BR9711879A publication Critical patent/BR9711879A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
BR9711879A 1996-10-08 1997-10-03 Derivados de 1h - pirido ¬3,4-b¾ indol -4- carboxamida sua prepara-Æo e sua aplica-Æo em terap-utica BR9711879A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9612229A FR2754262B1 (fr) 1996-10-08 1996-10-08 Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
PCT/FR1997/001750 WO1998015552A1 (fr) 1996-10-08 1997-10-03 DERIVES DE 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (1)

Publication Number Publication Date
BR9711879A true BR9711879A (pt) 1999-08-24

Family

ID=9496449

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711879A BR9711879A (pt) 1996-10-08 1997-10-03 Derivados de 1h - pirido ¬3,4-b¾ indol -4- carboxamida sua prepara-Æo e sua aplica-Æo em terap-utica

Country Status (33)

Country Link
US (1) US6075021A (pt)
EP (1) EP0934319B1 (pt)
JP (1) JP4227197B2 (pt)
KR (1) KR100488095B1 (pt)
CN (1) CN1089765C (pt)
AR (1) AR009112A1 (pt)
AT (1) ATE218567T1 (pt)
AU (1) AU721102B2 (pt)
BG (1) BG63751B1 (pt)
BR (1) BR9711879A (pt)
CA (1) CA2266376A1 (pt)
CO (1) CO4910141A1 (pt)
CY (1) CY2291B1 (pt)
CZ (1) CZ298906B6 (pt)
DE (1) DE69713124T2 (pt)
DK (1) DK0934319T3 (pt)
EE (1) EE03830B1 (pt)
ES (1) ES2178008T3 (pt)
FR (1) FR2754262B1 (pt)
HK (1) HK1023338A1 (pt)
HU (1) HUP9904623A3 (pt)
IL (1) IL129018A0 (pt)
NO (1) NO311938B1 (pt)
NZ (1) NZ334708A (pt)
PL (1) PL188244B1 (pt)
PT (1) PT934319E (pt)
RU (1) RU2180904C2 (pt)
SK (1) SK282970B6 (pt)
TR (1) TR199900712T2 (pt)
TW (1) TW461889B (pt)
UA (1) UA57037C2 (pt)
WO (1) WO1998015552A1 (pt)
ZA (1) ZA978970B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766823B1 (fr) * 1997-07-30 1999-10-08 Synthelabo Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2788696B1 (fr) * 1999-01-26 2004-03-05 Synthelabo Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2811990A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2833953B1 (fr) * 2001-12-21 2004-12-03 Sanofi Synthelabo DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2838124B1 (fr) 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
PA8586801A1 (es) * 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
BRPI0407052A (pt) * 2003-01-27 2006-01-17 Pfizer Inibidores da hiv-integrase, composições farmacêuticas, e métodos para sua utilização
BRPI0510319A (pt) * 2004-04-26 2007-10-16 Pfizer inibidores da enzima integrase de hiv
DE602005002746T2 (de) * 2004-04-26 2008-02-07 Pfizer Inc. Inhibitoren des hiv-integrase-enzyms
JP5483874B2 (ja) * 2005-05-05 2014-05-07 サノフィ−アベンティス・ユー・エス・エルエルシー 安定なナノ粒子処方物
BRPI0616657A2 (pt) * 2005-10-07 2011-06-28 Pfizer Prod Inc inibidores da enzima hiv integrase
UA95788C2 (en) 2005-12-15 2011-09-12 Ф. Хоффманн-Ля Рош Аг Fused pyrrole derivatives
WO2007143597A2 (en) * 2006-06-05 2007-12-13 Novartis Ag Organic compounds
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
KR100688448B1 (ko) * 2006-12-06 2007-03-02 (주)경진건축사사무소 건축물 내부 조적구조

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724384B1 (fr) * 1994-09-14 1999-04-16 Cemaf Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament

Also Published As

Publication number Publication date
CA2266376A1 (en) 1998-04-16
SK45199A3 (en) 2000-02-14
HK1023338A1 (en) 2000-09-08
NZ334708A (en) 2000-10-27
US6075021A (en) 2000-06-13
AU4559497A (en) 1998-05-05
CN1233248A (zh) 1999-10-27
EP0934319B1 (fr) 2002-06-05
BG103301A (en) 2000-05-31
AR009112A1 (es) 2000-03-08
EE03830B1 (et) 2002-08-15
JP4227197B2 (ja) 2009-02-18
FR2754262A1 (fr) 1998-04-10
CO4910141A1 (es) 2000-04-24
KR100488095B1 (ko) 2005-05-09
NO991624L (no) 1999-06-07
CY2291B1 (en) 2003-07-04
CN1089765C (zh) 2002-08-28
DK0934319T3 (da) 2002-09-30
PT934319E (pt) 2002-10-31
UA57037C2 (uk) 2003-06-16
FR2754262B1 (fr) 1998-10-30
BG63751B1 (bg) 2002-11-29
KR20000048992A (ko) 2000-07-25
IL129018A0 (en) 2000-02-17
RU2180904C2 (ru) 2002-03-27
WO1998015552A1 (fr) 1998-04-16
CZ298906B6 (cs) 2008-03-12
ATE218567T1 (de) 2002-06-15
NO991624D0 (no) 1999-04-06
DE69713124D1 (de) 2002-07-11
ZA978970B (en) 1998-04-20
TW461889B (en) 2001-11-01
NO311938B1 (no) 2002-02-18
ES2178008T3 (es) 2002-12-16
TR199900712T2 (xx) 1999-06-21
JP2001508403A (ja) 2001-06-26
EE9900155A (et) 1999-12-15
PL332643A1 (en) 1999-09-27
AU721102B2 (en) 2000-06-22
PL188244B1 (pl) 2005-01-31
CZ119399A3 (cs) 1999-07-14
HUP9904623A3 (en) 2001-03-28
HUP9904623A2 (hu) 2000-06-28
EP0934319A1 (fr) 1999-08-11
SK282970B6 (sk) 2003-01-09
DE69713124T2 (de) 2003-01-30

Similar Documents

Publication Publication Date Title
NL300295I2 (nl) 3,3-diarylpropylaminen, de toepassing en bereidinghiervan
BR9708400A (pt) Composição sua preparação e uso
PT1127052E (pt) 2-fenilbenzimidazois substituidos sua preparacao e aplicacao
BR9711879A (pt) Derivados de 1h - pirido ¬3,4-b¾ indol -4- carboxamida sua prepara-Æo e sua aplica-Æo em terap-utica
ZA989505B (en) Substituted isoquinoline-3-carboxamides their preparation and their use as pharmaceuticals
PT832104E (pt) Derivados de dolastatina sua preparacao e utilizacao
PT1073672E (pt) Compostos anti-picornavirus, sua preparacao e utilizacao
IL111148A0 (en) Imidazol-4- ylpiperidine derivatives, their preparation and their application in therapeutics
EE200000094A (et) Uued plokk-kopolümeerid ja nende saamine
MX9101341A (es) Derivados de 2-aminopiridina-4-carboxamida,su preparacion y su aplicacion en terapeutica
ZA988921B (en) 3,4-diarylthiazolin-2-one or -2-thione derivatives their methods of preparation and their uses in therapeutics
PT1000063E (pt) Derivados de 4-oxo-3,5-di-hidro-4h-piridazino¬4,5-b|indole-1-acetamida processo para sua preparacao e sua aplicacao em terapeutica
IL118644A (en) N-¬(1,4-diazabicyclo¬2.2.2¾oct-2-YL)methyl¾benzamide derivatives their preparation and their application in therapeutics
PT764694E (pt) Corantes reactivos sua preparacao e utilizacao
HUP9904091A3 (en) N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics
IL122372A0 (en) Substituted piperidine-2,6-diones their preparation and use
IL131247A0 (en) Cash protein its preparation and use
EP1302770A4 (en) PARTICLE MARKING PROTEIN AND IMMUNO-CHROMATOGRAPHER USING THE SAME
PT931109E (pt) Corantes tetrakisazoicos sua preparacao e sua utilizacao
ZA977767B (en) Benzylamine derivatives, their preparation and their application in therapeutics.
GB2332671B (en) Acetals, their preparation and their use
IL129546A0 (en) N-(imidazolylbutyl)benzenesulphonamide derivatives their preparation and their application in therapeutics
FR2735470B1 (fr) Nitrocetones et nitroximes, leur preparation et leur application en therapeutique
ZA982358B (en) Benzenesulphonamide derivatives their preparation and their application in therapeutics
EP1132472A4 (en) NEW PROTEIN AND ITS APPLICATION

Legal Events

Date Code Title Description
PC Transfer

Free format text: SANOFI-SYNTHELABO (FR)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/10/1997, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2259 DE 22-04-2014 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.